The global pandemic, with its still unfolding morbidity and mortality consequences and lethal potential, has further raised the bar on already-conscientious nurses and other healthcare providers at the patient point of care. The very technology which has vastly improved patient outcomes, facilitated patient tracking and diagnosis, and greatly diminished the risk of medical error, does itself present a source of infection if not considered in the same realm as other contamination risks.
Speakers
Moderator: Lillee Smith Gelinas, RN, MSN, CPPS, FAAN
Institute for Patient Safety University of North Texas Health Science Center, Fort Worth, TX
Daniel Colling, BSc, RN
Global Lead Healthcare Industry Solutions
HP Inc.
Elie F. Berbari, MD
Chair of Infectious Diseases
Mayo Clinic Rochester, Minnesota
Doe Kley, BS, RN, MPH, CIC, T-CHEST
Senior Infection Preventionist for The Clorox Company, Lecturer for The Ohio State University
The Clorox Company
Sean P. Spina, BSc(Pharm), ACPR, PharmD, FCSHP
Coordinator of Clinical Pharmacy Services
Royal Jubilee Hospital, Victoria, British Columbia, Canada
Sandra Dunford, RN, BSN, CIC
Infection Prevention and Control Consultant
Island Health Victoria, British Columbia Canada